BRAF and colorectal carcinoma: Therefore, we hypothesised that CIMP in CRC would result from activating mutations in either BRAF or KRAS. From this point of view, it might be sufficient to summarise the features of methylation by using the MLH1, MGMT, and SFRP2 genes.